Friday, July 30, 2010

FDA Allows Frankestein Experiments to Proceed

FDA OKs First Embryonic Stem Cell Research Trial on Humans, Despite Concerns
Washington, DC (LifeNews.com) -- The Obama administration has approved the bid by cloning company Geron to undertake the first trial involving the use of embryonic stem cells in humans. They have never been used before in people because the cells cause tumors and have immune system rejection issues when tried in animals.

Scientists and pro-life advocates say human embryonic stem cells are not ready for trial because problems associated with the cells in animals haven't been solved. The embryonic stem cells still cause tumors and have issues with the immune system rejecting the injection of the cells.

The Food and Drug Administration has initially placed the trial on hold but Geron indicated today that the agency is now allowing it to proceed with an early stage trial on an stem cell therapy for acute spinal cord injury...
More here at LifeNews.com

No comments:

Post a Comment

Please keep your comments civil and respectful!